Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision Medicine

Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision Medicine

Show other versions (1)

Shifting from the historical TNM paradigm to the determination of molecular and genetic subtypes of tumors has been a major improvement to better picture cancerous diseases. The sharper the picture is, the better will be the possibility to develop subsequent strategies, thus achieving higher efficac...

Full description

Bibliographic Details
Main Authors:	Adel Gouri, Aoulia Dekaken, Khalid El Bairi, Arifa Aissaoui, Nihad Laabed, Mohamed Chefrour, Joseph Ciccolini, Gérard Milano, Sadek Benharkat
Format:	Article
Language:	English
Published:	SAGE Publishing 2016-01-01
Series:	Biomarker Insights
Online Access:	https://doi.org/10.4137/BMI.S33372

Similar Items

Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision Medicine
by: Adel Gouri, et al.
Published: (2016-08-01)

The association between adverse events and outcome under checkpoint inhibitors: Where is the deal?
by: Gerard Milano, et al.
Published: (2021-01-01)

ALK inhibitors fuel ALK resistance mutation: Precision medicine takes on drug resistance
by: Gouri S Bhattacharyya, et al.
Published: (2020-01-01)

Role of Her-2 in Gastrointestinal Tumours beyond Gastric Cancer: A Tool for Precision Medicine
by: Csongor G. Lengyel, et al.
Published: (2021-12-01)

The effect of anti-human plasminogen monoclonal antibodies on Glu-plasminogen activation by plasminogen activators
by: M. Akrami, et al.
Published: (2006-07-01)

Precision Chemistry for Precision Medicine
by: George M. Church
Published: (2015-03-01)

Precision targeting of the plasminogen activator inhibitor‐1 mechanism increases efficacy of fibrinolytic therapy in empyema
by: Galina Florova, et al.
Published: (2021-05-01)

Characterization of plasmin, plasminogen and plasminogen activator in goat milk
by: F. Polidori, et al.
Published: (2011-03-01)

The microbiome in precision medicine: the way forward
by: Joseph F. Petrosino
Published: (2018-02-01)

Precision Medicine
by: João Renato Rebello Pinho

Plasminogen Receptors
by: Lindsey A. Miles, et al.
Published: (2012-01-01)

From Plasminogen to Plasmin: Role of Plasminogen Receptors in Human Cancer
by: Miroslava Didiasova, et al.
Published: (2014-11-01)

THE LEVELS OF PLASMINOGEN AND INHIBITOR OF PLASMINOGEN ACTIVATORS OF TYPE 1 IN ANTIPHOSPHOLIPID SYNDROME
by: E V Ostryakova, et al.
Published: (2012-05-01)

The study of the expression of plasminogen activator and plasminogen activator inhibitor in radicular cysts
by: Weng, Sheng-Feng, et al.
Published: (2004)

Precision Medicine and Precision Nursing: The Era of Biomarkers and Precision Health
by: Ielapi N, et al.
Published: (2020-12-01)

Precision Medicine: The new era in medicine
by: Marinka Twilt
Published: (2016-02-01)

Towards precision medicine
by: Sonata Jarmalaitė
Published: (2017-04-01)

Precision Medicine Initiative
by: Demetrius J. Porche DNS, PhD, FAANP, FAAN
Published: (2015-05-01)

Precision regenerative medicine
by: Amy L. Lightner, et al.
Published: (2021-01-01)

Precision medicine at the crossroads
by: Maynard V. Olson
Published: (2017-10-01)

Precision Medicine in Oncology
Published: (2019)

Plasminogen Receptors and Fibrinolysis
by: Lindsey A. Miles, et al.
Published: (2021-02-01)

The Chemistry of the Activation of Plasminogen
by: Cederholm-Williams, Stewart A.
Published: (1977)

Prothrombin and plasminogen activation
by: Douglas, Alexander Stuart
Published: (1975)

Fibrinolysis regulation by platelets retaining plasminogen and tissue-type plasminogen activator on their surface
by: T. Grinenko, et al.
Published: (2019-12-01)

Bacterial Plasminogen Receptors Utilize Host Plasminogen System for Effective Invasion and Dissemination
by: Sarbani Bhattacharya, et al.
Published: (2012-01-01)

Plasminogen and the Plasminogen Receptor, Plg-RKT, Regulate Macrophage Phenotypic, and Functional Changes
by: Juliana P. Vago, et al.
Published: (2019-06-01)

Anti-plasminogen antibodies in ANCA-associated vasculitis: An optimized anti-plasminogen assay.
by: Arda Göçeroğlu, et al.
Published: (2018-01-01)

Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
by: Kamlesh K. Gupta, et al.
Published: (2017-03-01)

Nominalism in Medicine: the case of personalized medicine or precision medicine
by: Italo Portioli
Published: (2017-11-01)

The Amarna Diplomacy in IR Perspective – A System of States in the Making
by: Alex Aissaoui
Published: (2018-09-01)

Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics
by: Anna Maria Piras, et al.
Published: (2020-11-01)

A novel serine protease secreted by medicinal maggots enhances plasminogen activator-induced fibrinolysis.
by: Mariena J A van der Plas, et al.
Published: (2014-01-01)

Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness
by: Christopher W. Seymour, et al.
Published: (2017-10-01)

Precision medicine and traditional chinese medicine of dialogue
by: Lou Xin, et al.
Published: (2017-01-01)

<i>PTEN</i> Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
by: Nicola Fusco, et al.
Published: (2020-06-01)

Plate-forme de composants logiciels pour la coordination des adaptations multiples en environnement dynamique
by: Chefrour, Djalel
Published: (2005)

Associations antimétabolites fluoropyrimidiques-thérapies ciblées : étude des déterminants moléculaires de réponse et non-réponse
by: Chefrour, Mohamed
Published: (2010)

Perspective for Precision Medicine for Tuberculosis
by: Christoph Lange, et al.
Published: (2020-10-01)

Precision Medicine for Lysosomal Disorders
by: Filippo Pinto e Vairo, et al.
Published: (2020-07-01)